The data displays the number of biopharma medicines in development as of May 2018, by therapeutic category. As of that moment, 1,120 medicines were in development for cancer and cancer-related conditions in the U.S.
Cancers | 1120 |
Rare diseases | 566 |
Neurologic disorders | 537 |
Autoimmune disorders | 311 |
Heart disease and stroke | 200 |
Diabetes/related conditions | 171 |
Mental health disorders | 135 |
Alzheimer's disease | 85 |